国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Hydrastis canadensis Photosystem II reaction center protein T (psbT), partial CSB-YP765935HDAJ
CSB-EP765935HDAJ
CSB-BP765935HDAJ
CSB-MP765935HDAJ
CSB-EP765935HDAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Calycanthus floridus var. glaucus 30S ribosomal protein S7, chloroplastic (rps7-A) CSB-YP765936CBM
CSB-EP765936CBM
CSB-BP765936CBM
CSB-MP765936CBM
CSB-EP765936CBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Calycanthus floridus var. glaucus Cytochrome b6-f complex subunit 8 (petN), partial CSB-YP765937CBM
CSB-EP765937CBM
CSB-BP765937CBM
CSB-MP765937CBM
CSB-EP765937CBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gossypium schwendimanii Maturase K (matK), partial CSB-YP765938GCAK
CSB-EP765938GCAK
CSB-BP765938GCAK
CSB-MP765938GCAK
CSB-EP765938GCAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eulemur mongoz NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L), partial CSB-YP765939EPH1
CSB-EP765939EPH1
CSB-BP765939EPH1
CSB-MP765939EPH1
CSB-EP765939EPH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Zamia furfuracea Photosystem II reaction center protein L (psbL), partial CSB-YP765940ZAAI
CSB-EP765940ZAAI
CSB-BP765940ZAAI
CSB-MP765940ZAAI
CSB-EP765940ZAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tamias bulleri Cytochrome c oxidase subunit 2 (MT-CO2), partial CSB-YP765941TDAB1
CSB-EP765941TDAB1
CSB-BP765941TDAB1
CSB-MP765941TDAB1
CSB-EP765941TDAB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Calycanthus floridus Photosystem II reaction center protein T (psbT), partial CSB-YP765942CBL
CSB-EP765942CBL
CSB-BP765942CBL
CSB-MP765942CBL
CSB-EP765942CBL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Liriodendron tulipifera Photosystem II reaction center protein L (psbL), partial CSB-YP765943LGR
CSB-EP765943LGR
CSB-BP765943LGR
CSB-MP765943LGR
CSB-EP765943LGR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drimys winteri Photosystem II reaction center protein L (psbL), partial CSB-YP765944DFB
CSB-EP765944DFB
CSB-BP765944DFB
CSB-MP765944DFB
CSB-EP765944DFB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Calycanthus floridus Cytochrome b559 subunit beta (psbF), partial CSB-YP765945CBL
CSB-EP765945CBL
CSB-BP765945CBL
CSB-MP765945CBL
CSB-EP765945CBL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acorus calamus Cytochrome b559 subunit beta (psbF), partial CSB-YP765946ACE
CSB-EP765946ACE
CSB-BP765946ACE
CSB-MP765946ACE
CSB-EP765946ACE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L), partial CSB-YP765947MOV1
CSB-EP765947MOV1
CSB-BP765947MOV1
CSB-MP765947MOV1
CSB-EP765947MOV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mustela eversmannii Cytochrome b (MT-CYB), partial CSB-YP765948MGAQ
CSB-EP765948MGAQ
CSB-BP765948MGAQ
CSB-MP765948MGAQ
CSB-EP765948MGAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Maturase K (matK), partial CSB-YP765949AQR
CSB-EP765949AQR
CSB-BP765949AQR
CSB-MP765949AQR
CSB-EP765949AQR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Equus grevyi Hemoglobin subunit alpha-2 (HBA2) CSB-YP765950EJB
CSB-EP765950EJB
CSB-BP765950EJB
CSB-MP765950EJB
CSB-EP765950EJB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Trachypithecus cristatus Beta-defensin 1 (DEFB1) CSB-YP765951TOY
CSB-EP765951TOY
CSB-BP765951TOY
CSB-MP765951TOY
CSB-EP765951TOY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hypsugo savii Sperm protamine P1 (PRM1) CSB-YP765952HDAR
CSB-EP765952HDAR
CSB-BP765952HDAR
CSB-MP765952HDAR
CSB-EP765952HDAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Papio cynocephalus Sperm protamine P1 (PRM1) CSB-YP765953PBR
CSB-EP765953PBR
CSB-BP765953PBR
CSB-MP765953PBR
CSB-EP765953PBR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pan troglodytes Tubulin beta chain (TUBB) CSB-YP765954EQV
CSB-EP765954EQV
CSB-BP765954EQV
CSB-MP765954EQV
CSB-EP765954EQV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>